High-Concentration, Low-Volume Subcutaneous Formulation

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Brian Kelley

Brian Kelley is vice president, bioprocess development at Genentech, Inc.

Articles by Brian Kelley

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

ByBenedicte Lebreton,Amber R. Cothran,Sandy Sargis,Melody Trexler-Schmidt,Binh Q. Thai,Brian Kelley,Gregory S. Blank,Stefanie Sze-Khoo

March 2nd 2009

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.

Latest Updated Articles

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies
March 2nd 2009